Literature DB >> 25957915

The increased Sprouty4 expression in response to serum is transcriptionally controlled by Specific protein 1.

Angelina Doriguzzi1, Barbara Haigl2, Andrea Gsur3, Hedwig Sutterlüty-Fall4.   

Abstract

Sprouty proteins control length and intensity of the intracellular signal transduction cascade activated by mitogens in the cellular environment. As part of a negative feedback loop, their expression is supposed to be elevated by the same factors. In this report, Sprouty4 expression in response to serum and the underlying regulatory mechanisms were investigated. We verified that Sprouty4 expression is activated by serum addition in all tested cells independent of their origin. Strict correlation between Sprouty4 protein levels and promoter activity indicates mainly transcriptional regulation of Sprouty4 serum-responsiveness. Induction of the mitogen-activated protein kinase pathway is required for Sprouty4 promoter activation in the presence of serum. Nonetheless, signal transduction via this pathway is not sufficient to fully induce the Sprouty4 promoter. Instead, deletion and mutation analysis identified two annotated Specific protein 1 binding sites as the critical cis-elements responsible for conferring the serum induction of the promoter. Corroborating, repressed Specific protein 1 activity or levels result in constitutive lowered transcriptional activity of the Sprouty4 promoter. These data demonstrate that Specific protein 1 plays a crucial role in the regulation of Sprouty4 in response to serum.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Negative feedback loop; Serum response; Sp1; Specific protein 1; Sprouty4 promoter

Mesh:

Substances:

Year:  2015        PMID: 25957915     DOI: 10.1016/j.biocel.2015.04.017

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Sprouty4 mRNA variants and protein expressions in breast and lung-derived cells.

Authors:  Angelina Doriguzzi; Jihen Salhi; Hedwig Sutterlüty-Fall
Journal:  Oncol Lett       Date:  2016-09-30       Impact factor: 2.967

2.  Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.

Authors:  Wai-Kin So; Jung-Chien Cheng; Yingtao Liu; Congjian Xu; Jianfang Zhao; Vincent T W Chang; Peter C K Leung
Journal:  Tumour Biol       Date:  2016-01-14

3.  MNS16A tandem repeat minisatellite of human telomerase gene: functional studies in colorectal, lung and prostate cancer.

Authors:  Philipp Hofer; Cornelia Zöchmeister; Christian Behm; Stefanie Brezina; Andreas Baierl; Angelina Doriguzzi; Vanita Vanas; Klaus Holzmann; Hedwig Sutterlüty-Fall; Andrea Gsur
Journal:  Oncotarget       Date:  2017-04-25

4.  A Sprouty4 Mutation Identified in Kallmann Syndrome Increases the Inhibitory Potency of the Protein towards FGF and Connected Processes.

Authors:  Astrid Stütz; Anna Z M Kamptner; Hedwig Sutterlüty
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

5.  SPRY4 promotes adipogenic differentiation of human mesenchymal stem cells through the MEK-ERK1/2 signaling pathway.

Authors:  Na Li; Yunfei Chen; Haiyan Wang; Jing Li; Robert Chunhua Zhao
Journal:  Adipocyte       Date:  2022-12       Impact factor: 3.553

6.  MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.

Authors:  Vanita Vanas; Barbara Haigl; Verena Stockhammer; Hedwig Sutterlüty-Fall
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

7.  Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells.

Authors:  Burcu Emine Celik-Selvi; Astrid Stütz; Christoph-Erik Mayer; Jihen Salhi; Gerald Siegwart; Hedwig Sutterlüty
Journal:  Cells       Date:  2019-08-01       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.